CDSs and sequential metabolic conversion BBB disruption for drug delivery to brain bioremovable, T moieties and modifier functions CDS novel methodologies targeting specific sites enzymatic, brain‐targeting/and eye‐targeting CDSs
Nicholas Bodor (Editor) -
Center for Drug Discovery, University of Florida, Gainesville, Florida, USA
Peter Buchwald (Editor) -
Diabetes Research Institute and Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, Florida, USA
Publication Details
Retrometabolic Drug Design and Targeting, pp.259-393